guozi
Lv1
80 积分
2023-03-20 加入
-
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial
2天前
已完结
-
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
2天前
已完结
-
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
3天前
已完结
-
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
3天前
已完结
-
Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial
3天前
已完结
-
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study
3天前
已完结
-
Current developments in gastric cancer: from molecular profiling to treatment strategy
27天前
已完结
-
Immune checkpoint inhibitors and cellular immunotherapy for advanced gastric, gastroesophageal cancer: a long pathway
27天前
已完结
-
Current neoadjuvant therapy for operable locally advanced esophageal cancer
27天前
已完结
-
New molecular and immunologic targets of therapy for esophageal cancer and the prospects for ongoing and future clinical trials
27天前
已完结